SBI Securities’s Integra LifeSciences IART Stock Holding History

SBI Securities’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,021	Closed	-$9.62K	–	4135
2026 Q1	$9.62K	Buy	+1,021	New	+$11.2K	﹤0.01%	1735
2025 Q4	–	Sell	-2	Closed	-$29	–	4123
2025 Q3	$29	Sell	2 -1	-33%	-$14	﹤0.01%	3842
2025 Q2	$37	Sell	3 -10	-77%	-$145	﹤0.01%	3784
2025 Q1	$286	Buy	13 +3	+30%	+$71	﹤0.01%	3086
2024 Q4	$227	Buy	+10	New	+$218	﹤0.01%	3192

Other funds holding IART

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

SBI Securities's IART Position: Q2 2026 in Review

SBI Securities sold out of Integra LifeSciences (IART) in Q2 2026, closing a stake of 1,021 shares — an estimated $9.62K sold.

SBI Securities first reported a position in IART in Q4 2024 and held it in 5 quarters. The position peaked at $9.62K in Q1 2026. 213 funds tracked by Wall St. Rank hold IART as of Q2 2026.

SBI Securities reported no remaining Integra LifeSciences position as of Q2 2026 after selling out during the quarter.
SBI Securities sold 1,021 Integra LifeSciences shares in Q2 2026, an estimated $9.62K.
SBI Securities first reported a position in Integra LifeSciences in Q4 2024 and held it in 5 quarters.
SBI Securities's Integra LifeSciences position peaked at $9.62K in Q1 2026.
213 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.